Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06421012

Preoxygenation for Tracheal Aspirations in Intensive Care

Clearing the airways is a complex phenomenon involving the production of secretions, the nature of mucus (viscosity, elasticity, stringiness, and adhesiveness), ciliary movement, and coughing. In intubated and ventilated patients, endotracheal suctioning occur when the patient is "unable to clear the airways of obstructions hindering the free passage of air." These suctioning can lead to transient desaturation exacerbated by a decrease in cardiac output due to increased mean arterial pressure, promoting cardiac arrhythmias. To minimize these effects, it is recommended to perform additional preoxygenation, by increasing the fraction of O2 in the air delivered to the patient by the ventilator 2-3 minutes before the procedure. These longstanding recommendations were reiterated in 2022, based on outdated studies involving systematic suctioning that required disconnecting the patient from the ventilator.

Currently, suctioning are performed on-demand, based on the patient's congestion status, either through the endotracheal tube cap or a "closed system." Desaturations have become infrequent without establishing that additional preoxygenation can prevent them. Moreover, additional preoxygenation is not without risks. By inducing de-nitrogenation atelectasis with a loss of lung volume, it can exacerbate pre-existing lung injuries in the most severe patients. In less severe cases, preoxygenation leads to transient hyperoxia, with various deleterious effects impacting patient prognosis. Thus, a short-term risk, such as deep desaturations, must be balanced against a medium-term risk of hyperoxia and de-nitrogenation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Clearing the airways is a complex phenomenon involving the production of secretions, the nature of mucus (viscosity, elasticity, stringiness, and adhesiveness), ciliary movement, and coughing. Endotracheal suctioning are performed when the patient is "unable to clear the airways of obstructions hindering the free passage of air." Classically, endotracheal suctioning cause transient desaturation exacerbated by a decrease in cardiac output due to an increase in mean arterial pressure, promoting cardiac arrhythmias. To minimize these effects, it is recommended to perform additional preoxygenation, i.e., increasing the fraction of O2 in the air delivered to the patient by the ventilator 2-3 minutes before the procedure. These longstanding recommendations were reiterated in 2022, based on outdated studies involving systematic suctioning and/or disconnecting the patient from the ventilator.

Today, suctioning are performed on-demand, based on the patient's congestion status, either through the endotracheal tube cap or a "closed system." Desaturations have become rare without establishing that additional preoxygenation can prevent them. Moreover, additional preoxygenation is not without risks. In the short term, it induces de-nitrogenation atelectasis resulting in a loss of lung volume that can worsen pre-existing lung injuries in the most severe patients. In less severe cases, preoxygenation is responsible for transient hyperoxia, with various deleterious effects impacting patient prognosis. Thus, a short-term risk, such as deep desaturations, is juxtaposed with a medium-term risk of hyperoxia and de-nitrogenation.

The investigators hypothesize that the absence of additional preoxygenation is not inferior, in terms of deep desaturations, to the strategy with additional preoxygenation, and it would avoid exposing patients to the risks of de-nitrogenation-induced atelectasis and hyperoxia.

The investigators retained a margin of non-inferiority for the relative risk of 1.1, i.e. an increase of 10% of deep desaturations.

The main analysis will be performed on the per-protocol population (more conservative in non-inferiority trials).The per-protocol population will include patients who had at least one suctioning and for whom the additional preoxygenation strategy allocated by randomisation was followed in at least 70% of all suctioning reported in the patient's care record. Patients who stopped their participation in the study before endpoint timeframe and those who had never had an suctioning will not be included in the per protocol population.

The unit of analysis will be the patient, and a rate of suctioning leading to deep desaturation will be calculated for each patient, as described in the primary endpoint. The mean rate of suctioning leading to deep desaturation will then be calculated by treatment group (with additional preoxygenation / without additional preoxygenation).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Hospitalized in ICU, under invasive mechanical ventilation for less than 24 hours
  • Information and signature of consent by patient or relative/trusted person, or emergency inclusion procedure

Exclusion criteria

  • Patient on ECMO
  • Not affiliated to a social security system
  • Pregnant
  • Under legal protection (curatorship, guardianship or safeguard of justice)
  • Patient under AME
  • Patient included in another interventional study that may have an impact on the evaluation criteria of the present study

Treatment and study plan

Experimental : Patients without additional preoxygenation

Procedure

Throughout the entire period of their mechanical ventilation, patients will not receive additional preoxygenation before any endotracheal suctioning; their FiO2 value will be maintained constant

Active Comparator : Patients with additional preoxygenation

Procedure

Throughout the entire period of their mechanical ventilation, patients will receive additional preoxygenation at 100% FiO2 for a systematic 2-minute duration prior to any endotracheal suction. Subsequently, the FiO2 will be reset to the previous default value.

Primary outcomes

  1. Rate of suctioning leading to deep desaturation

    Time frame: from Day 0 to ventilator weaning, and at the latest Day 28

    It will be calculated for each patient as the number of suctioning leading to deep desaturation (SpO2 88% or less, and 85% or less for patients with chronic obstructive pulmonary disease COPD), divided by the total number of endotracheal suctioning throughout the period. Oxygen saturation values will be collected every minute during the 15 minutes post-suctioning. Endotracheal suctioning in patients already ventilated with 100% FiO2 started prior to the decision to aspirate will not be taken into account

Secondary outcomes

  1. Suctioning rate leading to severe desaturation

    Time frame: From Day 0 to ventilator weaning, and at the latest Day 28

    It will be calculated for each patient as the number of suctioning leading to severe desaturation (SpO2 85% or less, and 80% or less for patients with COPD), divided by the total number of endotracheal suctioning throughout the period

  2. Number of ventilator free days at D28

    Time frame: From Day 0 to Day 28

    Number of days without ventilation. In case of death value will be set to zero

  3. Ventilator-associated pneumonia

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Ventilator-associated pneumonia, as defined by the Formalized Recommendation of Experts from the SFAR-SRLF in 2017

  4. Intensive care delirium

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Delirium occurring in ICU, defined by a positive result on the CAM-ICU clinical assessment tool specific to ICU delirium

  5. Composite criteria of ischemic phenomena in ICU, including one of the following: stroke, myocardial infarction, digestive ischemia

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Composite criteria including at least one of the following: ischemic stroke, myocardial infarction, digestive ischemia

  6. Ischemic stroke

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Ischemic stroke occurring in intensive care, defined by the combination of the onset of focal motor deficit and compatible cerebral imaging

  7. Myocardial infarction

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Myocardial infarction occurring in intensive care, defined by an acute coronary syndrome with ST segment elevation and troponin elevation

  8. Digestive ischemia

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Digestive ischemia occurring in intensive care, diagnosed by CT scan or digestive endoscopy

  9. Cardiac arrest

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Cardiac arrest occuring in intensive care

  10. Acute kidney injury

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Acute kidney injury occurring in intensive care, defined by the initiation of renal replacement therapy

  11. First bowel movements

    Time frame: From Day 0 to ICU-discharge, and at the latest Day 28

    Time to first bowel movements

  12. ICU discharge vital status

    Time frame: At ICU discharge and at the latest Day 90

    Vital status at discharge from ICU

  13. Hospital discharge vital status

    Time frame: At hospital discharge, and at the latest Day 90

    Vital status at discharge from hospital

  14. Mean saturation over 15 minutes post-suctioning

    Time frame: From Day 0 to ventilator weaning, and at the latest Day 28

    Mean saturation over all the period of 15 minutes post suctioning

  15. Absolute variation between saturation before suctioning and minimum saturation over 15 minutes post-suctioning

    Time frame: From Day 0 to ventilator weaning, and at the latest Day 28

    Saturation over all the period of 15 minutes post suctioning

  16. Acute respiratory distress syndrome (ARDS)

    Time frame: From Day 0 to hospital discharge, and at the latest Day 90

    ARDS according to the Berlin definition, characterized by 1) acute respiratory failure evolving for a week or less, 2) bilateral opacities on thoracic imaging, 3) no evidence of predominant hydrostatic edema, 4) hypoxemia with a PaO2/FIO2 ratio < 300 mmHg for positive end-expiratory pressure set at 5 cmH2O or more, with 3 severity stages defined based on hypoxemia

  17. Length of ICU stay

    Time frame: at ICU discharge, and at the latest Day 90

    Length of stay in intensive care

  18. Length of hospital stay

    Time frame: at hospital discharge, and at the latest Day 90

    Length of stay in hospital

  19. Time in minutes between endotracheal suctioning and eventual desaturation

    Time frame: From Day 0 to ventilator weaning, and at the latest Day 28

    For each desaturation, time in minutes between endotracheal suctioning and desaturation

Study contacts

Contact information is provided by the study sponsor or research team.

Claire FAZILLEAU

CONTACT

[email protected]

01 42 16 22 75

Jean Michel CONSTANTIN, Pr

CONTACT

[email protected]

01 42 17 73 05

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Preoxygenation for Tracheal Aspirations in Intensive Care, a Randomized Controlled Trial

Acronym: POXTRA

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
May 20, 2024
Registry last updated
May 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.